Imugene Ltd showcases new PD1-Vaxx data at World Conference

Imugene Ltd (ASX:IMU, OTC:IUGNF) has presented findings from its PD1-Vaxx trial in non-small cell lung cancer patients at the International Association for...

Related Keywords

Vienna , Wien , Austria , Leslie Chong , Michael Boyer , Imugene Ltd , International Association , Lung Cancer , World Conference , Professor Michael Boyer , Vaxx Phase ,